BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22726230)

  • 21. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
    Kawada K; Taira N; Mizoo T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kochi M; Abe Y; Nishiyama K; Iwamoto T; Ikeda H; Shien T; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Toyooka S
    Breast Cancer; 2021 Mar; 28(2):478-487. PubMed ID: 33185851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interaction of body mass index and a polymorphism in gene of catalytic subunit of glutamate-cysteine ligase on breast cancer risk among Chinese women].
    Lin W; Tang LY; Cen YL; Lin Y; Su FX; Jia WH; Ren ZF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Nov; 34(11):1115-9. PubMed ID: 24517946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.
    Rudolph A; Song M; Brook MN; Milne RL; Mavaddat N; Michailidou K; Bolla MK; Wang Q; Dennis J; Wilcox AN; Hopper JL; Southey MC; Keeman R; Fasching PA; Beckmann MW; Gago-Dominguez M; Castelao JE; Guénel P; Truong T; Bojesen SE; Flyger H; Brenner H; Arndt V; Brauch H; Brüning T; Mannermaa A; Kosma VM; Lambrechts D; Keupers M; Couch FJ; Vachon C; Giles GG; MacInnis RJ; Figueroa J; Brinton L; Czene K; Brand JS; Gabrielson M; Humphreys K; Cox A; Cross SS; Dunning AM; Orr N; Swerdlow A; Hall P; Pharoah PDP; Schmidt MK; Easton DF; Chatterjee N; Chang-Claude J; García-Closas M
    Int J Epidemiol; 2018 Apr; 47(2):526-536. PubMed ID: 29315403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between common breast cancer susceptibility variants, genetic ancestry, and nongenetic risk factors in Hispanic women.
    Fejerman L; Stern MC; John EM; Torres-Mejía G; Hines LM; Wolff RK; Baumgartner KB; Giuliano AR; Ziv E; Pérez-Stable EJ; Slattery ML
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1731-8. PubMed ID: 26364163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk.
    Mitrunen K; Kataja V; Eskelinen M; Kosma VM; Kang D; Benhamou S; Vainio H; Uusitupa M; Hirvonen A
    Pharmacogenetics; 2002 Jan; 12(1):67-72. PubMed ID: 11773866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
    Rudolph A; Hein R; Lindström S; Beckmann L; Behrens S; Liu J; Aschard H; Bolla MK; Wang J; Truong T; Cordina-Duverger E; Menegaux F; Brüning T; Harth V; ; Severi G; Baglietto L; Southey M; Chanock SJ; Lissowska J; Figueroa JD; Eriksson M; Humpreys K; Darabi H; Olson JE; Stevens KN; Vachon CM; Knight JA; Glendon G; Mulligan AM; Ashworth A; Orr N; Schoemaker M; Webb PM; ; ; Guénel P; Brauch H; Giles G; García-Closas M; Czene K; Chenevix-Trench G; Couch FJ; Andrulis IL; Swerdlow A; Hunter DJ; Flesch-Janys D; Easton DF; Hall P; Nevanlinna H; Kraft P; Chang-Claude J;
    Endocr Relat Cancer; 2013 Dec; 20(6):875-87. PubMed ID: 24080446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MassARRAY analysis of twelve cancer related SNPs in esophageal squamous cell carcinoma in J&K, India.
    Shah R; Sharma V; Bhat A; Singh H; Sharma I; Verma S; Bhat GR; Sharma B; Bakshi D; Kumar R; Dar NA
    BMC Cancer; 2020 Jun; 20(1):497. PubMed ID: 32487238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.
    Manjer J; Malina J; Berglund G; Bondeson L; Garne JP; Janzon L
    Int J Cancer; 2001 Jun; 92(6):919-22. PubMed ID: 11351317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study.
    Ricks-Santi LJ; Nie J; Marian C; Ochs-Balcom HM; Trevisan M; Edge SB; Kanaan Y; Freudenheim JL; Shields PG
    Genet Epidemiol; 2013 Jul; 37(5):504-11. PubMed ID: 23674270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk.
    Ziva Cerne J; Stegel V; Gersak K; Novakovic S
    Mol Med Rep; 2011; 4(1):175-9. PubMed ID: 21461582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women.
    Sangrajrang S; Sato Y; Sakamoto H; Ohnami S; Khuhaprema T; Yoshida T
    Breast Cancer Res Treat; 2010 Oct; 123(3):885-93. PubMed ID: 20180013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk.
    Ahn J; Gammon MD; Santella RM; Gaudet MM; Britton JA; Teitelbaum SL; Terry MB; Neugut AI; Josephy PD; Ambrosone CB
    Cancer Res; 2004 Oct; 64(20):7634-9. PubMed ID: 15492293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple exposure to environmental factors and variations in CYP27B1 and the microRNA-binding site of IL-13 are associated with breast cancer risk.
    Zhang N; Chen Y; Li S; Yin H; Li L; Shan M; Long Z; Tian J; Li J; Yu H; Xie K; Wu Z; Daria V; Wang F; Zhao Y
    Cancer Med; 2019 Jun; 8(6):3237-3249. PubMed ID: 31041852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden).
    Jernström H; Bendahl PO; Lidfeldt J; Nerbrand C; Agardh CD; Samsioe G
    Cancer Causes Control; 2003 Sep; 14(7):673-80. PubMed ID: 14575365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
    Maas P; Barrdahl M; Joshi AD; Auer PL; Gaudet MM; Milne RL; Schumacher FR; Anderson WF; Check D; Chattopadhyay S; Baglietto L; Berg CD; Chanock SJ; Cox DG; Figueroa JD; Gail MH; Graubard BI; Haiman CA; Hankinson SE; Hoover RN; Isaacs C; Kolonel LN; Le Marchand L; Lee IM; Lindström S; Overvad K; Romieu I; Sanchez MJ; Southey MC; Stram DO; Tumino R; VanderWeele TJ; Willett WC; Zhang S; Buring JE; Canzian F; Gapstur SM; Henderson BE; Hunter DJ; Giles GG; Prentice RL; Ziegler RG; Kraft P; Garcia-Closas M; Chatterjee N
    JAMA Oncol; 2016 Oct; 2(10):1295-1302. PubMed ID: 27228256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
    Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
    Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
    Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer: a candidate gene approach across the estrogen metabolic pathway.
    Justenhoven C; Hamann U; Schubert F; Zapatka M; Pierl CB; Rabstein S; Selinski S; Mueller T; Ickstadt K; Gilbert M; Ko YD; Baisch C; Pesch B; Harth V; Bolt HM; Vollmert C; Illig T; Eils R; Dippon J; Brauch H
    Breast Cancer Res Treat; 2008 Mar; 108(1):137-49. PubMed ID: 17588204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.